#clinical trial — Saturday, October 03, 2026 (2 items)
| 1 | ℹ |
Ceftazidime-avibactam for the treatment of infections caused by carbapenem-resistant Gram-negative pathogens in Chinese patients: A phase IV, multi-center, open‑label study.
(linkinghub.elsevier.com)
|
International Journal of Antimicrobial Agents 2026-10-03 | #amr #carbapenem-resistance #pneumonia #clinical trial #gram-negative | |
| 1 | ℹ |
Evaluation of Three Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccines RSV/DeltaNS2/Delta1313/I1314L, RSV/6120/DeltaNS2/1030s, and RSV/276 in RSV Seronegative Children.
(academic.oup.com)
|
Journal of Infectious Diseases 2026-10-03 | #vaccination #immunogenicity #rsv #clinical trial #pediatrics |